Diagnosis and treatment of depression in patients with congestive heart failure: A review of the literature

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 15, Issue 4, 2013, Pages

  Rustad, James K ^a,b   Stern, Theodore A ^c   Hebert, Kathy A ^d   Musselman, Dominique L ^d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; ANTITHROMBOCYTIC AGENT; ARIPIPRAZOLE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CLOMIPRAMINE; CYTOCHROME P450; DECONGESTIVE AGENT; DESIPRAMINE; DEXMETHYLPHENIDATE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; FLUVOXAMINE MALEATE; IMIPRAMINE; IRBESARTAN; LOSARTAN; METHYLPHENIDATE; METOPROLOL SUCCINATE; METOPROLOL TARTRATE; MILNACIPRAN; MIRTAZAPINE; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PROPRANOLOL; PROTRIPTYLINE; QUETIAPINE; SELEGILINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE; WARFARIN;

AGED; ANGINA PECTORIS; AUTONOMIC NEUROPATHY; BECK DEPRESSION INVENTORY; BEDTIME DOSAGE; BLOOD PRESSURE; BLURRED VISION; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; CONGESTIVE HEART FAILURE; CONSTIPATION; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HAMILTON SCALE; HEART ARRHYTHMIA; HEART CONDUCTION; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART RATE VARIABILITY; HEART VENTRICLE EXTRASYSTOLE; HOSPITALIZATION; HUMAN; HYPERTENSIVE CRISIS; HYPOTENSION; INSOMNIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; META ANALYSIS; MORTALITY; ORTHOSTATIC HYPOTENSION; PATHOPHYSIOLOGY; PNEUMONIA; PREVALENCE; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SHORT FORM 36; SIDE EFFECT; SINUS TACHYCARDIA; SYSTEMATIC REVIEW; TACHYCARDIA; THROMBOCYTE FUNCTION; UNSPECIFIED SIDE EFFECT; URINE INCONTINENCE; WEIGHT CHANGE; XEROSTOMIA; ZUNG SELF RATING DEPRESSION SCALE;

EID: 84884272518     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.13r01511     Document Type: Review

References (144)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. National Comorbidity Survey Replication (NCS-R) twelve-month prevalence estimates. http://www.hcp.med.harvard.edu/ncs/ftpdir/NCS-R_12-month_Prevalence_Estimates.pdf. Accessed March 23, 2013.
3. National Comorbidity Survey Replication (NCS-R) lifetime prevalence estimates. http://www.hcp.med.harvard.edu/ncs/ftpdir/NCS-R_Lifetime_Prevalence_Estimates.pdf. Accessed on March 23, 2013.
4. Frasure-Smith N, Lespérance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA. 1993;270(15):1819-1825. PubMed doi:10.1001/jama.1993.03510150053029 Show Abstract
5. Schleifer SJ, Macari-Hinson MM, Coyle DA, et al. The nature and course of depression following myocardial infarction. Arch Intern Med. 1989;149(8):1785-1789. PubMed doi:10.1001/archinte.1989.00390080059014 Show Abstract
6. Thombs BD, Bass EB, Ford DE, et al. Prevalence of depression in survivors of acute myocardial infarction. J Gen Intern Med. 2006;21(1):30-38. PubMed doi:10.1111/j.1525-1497.2005.00269.x Show Abstract
7. Connerney I, Shapiro PA, McLaughlin JS, et al. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet. 2001;358(9295):1766-1771. PubMed doi:10.1016/S0140-6736(01)06803-9 Show Abstract
8. Celano CM, Huffman JC. Depression and cardiac disease: a review. Cardiol Rev. 2011;19(3):130-142. PubMed doi:10.1097/CRD.0b013e31820e8106 Show Abstract
9. Gheorghiade M, Sopko G, De Luca L, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation. 2006;114(11):1202-1213. PubMed doi:10.1161/CIRCULATIONAHA.106.623199 Show Abstract
10. Heidenreich PA, Trogdon JG, Khavjou OA, et al; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933-944. PubMed doi:10.1161/CIR.0b013e31820a55f5 Show Abstract
11. McMurray JJ, Adamopoulos S, Anker SD, et al; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012;14(8):803-869. PubMed doi:10.1093/eurjhf/hfs105 Show Abstract
12. Cameron J, Worrall-Carter L, Riegel B, et al. Testing a model of patient characteristics, psychologic status, and cognitive function as predictors of self-care in persons with chronic heart failure. Heart Lung. 2009;38(5):410-418. PubMed doi:10.1016/j.hrtlng.2008.11.004 Show Abstract
13. DeWolfe A, Gogichaishvili I, Nozadze N, et al. Depression and quality of life among heart failure patients in Georgia, Eastern Europe. Congest Heart Fail. 2012;18(2):107-111. PubMed doi:10.1111/j.1751-7133.2011.00226.x Show Abstract
14. Fulop G, Strain JJ, Stettin G. Congestive heart failure and depression in older adults: clinical course and health services use 6 months after hospitalization. Psychosomatics. 2003;44(5):367-373. PubMed doi:10.1176/appi.psy.44.5.367 Show Abstract
15. Koenig HG. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry. 1998;20(1):29-43. PubMed doi:10.1016/S0163-8343(98)80001-7 Show Abstract
16. Rutledge T, Reis VA, Linke SE, et al. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48(8):1527-1537. PubMed doi:10.1016/j.jacc.2006.06.055 Show Abstract
17. Jiang W, Alexander J, Christopher E, et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med. 2001;161(15):1849-1856. PubMed doi:10.1001/archinte.161.15.1849 Show Abstract
18. Freedland KE, Rich MW, Skala JA, et al. Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med. 2003;65(1):119-128. PubMed doi:10.1097/01.PSY.0000038938.67401.85 Show Abstract
19. Carney RM, Rich MW, Freedland KE, et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med. 1988;50(6):627-633. PubMed Show Abstract
20. Hance M, Carney RM, Freedland KE, et al. Depression in patients with coronary heart disease: a 12-month follow-up. Gen Hosp Psychiatry. 1996;18(1):61-65. PubMed doi:10.1016/0163-8343(95)00100-X Show Abstract
21. Gonzalez MB, Snyderman TB, Colket JT, et al. Depression in patients with coronary artery disease. Depression. 1996;4(2):57-62. PubMed doi:10.1002/(SICI)1522-7162(1996)4:2<57::AID-DEPR3>3.0.CO;2-C Show Abstract
22. Lespérance F, Frasure-Smith N, Juneau M, et al. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 2000;160(9):1354-1360. PubMed doi:10.1001/archinte.160.9.1354 Show Abstract
23. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55(7):580-592. PubMed doi:10.1001/archpsyc.55.7.580 Show Abstract
24. Nemeroff CB, Goldschmidt-Clermont PJ. Heartache and heartbreak-the link between depression and cardiovascular disease. Nat Rev Cardiol. 2012;9(9):526-539. PubMed doi:10.1038/nrcardio.2012.91 Show Abstract
25. Kop WJ, Synowski SJ, Gottlieb SS. Depression in heart failure: biobehavioral mechanisms. Heart Fail Clin. 2011;7(1):23-38. PubMed doi:10.1016/j.hfc.2010.08.011 Show Abstract
26. York KM, Hassan M, Sheps DS. Psychobiology of depression/distress in congestive heart failure. Heart Fail Rev. 2009;14(1):35-50. PubMed doi:10.1007/s10741-008-9091-0 Show Abstract
27. Yamaji M, Tsutamoto T, Kawahara C, et al. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress. CircHeart Fail. 2009;2(6):608-615. doi:10.1161/CIRCHEARTFAILURE.109.868513 PubMed
28. Güder G, Bauersachs J, Frantz S, et al. Complementary and incremental mortality risk prediction by cortisol and aldosterone in chronic heart failure. Circulation. 2007;115(13):1754-1761. PubMed doi:10.1161/CIRCULATIONAHA.106.653964 Show Abstract
29. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311(13):819-823. PubMed doi:10.1056/NEJM198409273111303 Show Abstract
30. Isnard R, Pousset F, Chafirovskaïa O, et al. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Am Heart J. 2003;146(4):729-735. PubMed doi:10.1016/S0002-8703(03)00365-X Show Abstract
31. Anand IS, Fisher LD, Chiang YT, et al; Val-HeFT Investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation. 2003;107(9):1278-1283. PubMed doi:10.1161/01.CIR.0000054164.99881.00 Show Abstract
32. Benedict CR, Francis GS, Shelton B, et al; SOLVD Investigators. Effect of long-term enalapril therapy on neurohormones in patients with left ventricular dysfunction. Am J Cardiol. 1995;75(16):1151-1157. PubMed doi:10.1016/S0002-9149(99)80748-6 Show Abstract
33. Anker SD. Catecholamine levels and treatment in chronic heart failure. Eur Heart J. 1998;19(suppl F):F56-F61. PubMed Show Abstract
34. Packer M, Lee WH, Kessler PD, et al. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation. 1987;75(5 pt 2):IV80-IV92. PubMed Show Abstract
35. Francis GS, Cohn JN, Johnson G, et al. Plasma norepinephrine, plasma renin activity, and congestive heart failure: relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group. Circulation. 1993;87(suppl 6):VI40-VI48. PubMed Show Abstract
36. Kliks BR, Burgess MJ, Abildskov JA. Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion. Am J Cardiol. 1975;36(1):45-49. PubMed doi:10.1016/0002-9149(75)90866-8 Show Abstract
37. Podrid PJ, Fuchs T, Candinas R. Role of the sympathetic nervous system in the genesis of ventricular arrhythmia. Circulation. 1990;82(suppl 2):I103-I113. PubMed Show Abstract
38. Schwartz PJ. The autonomic nervous system and sudden death. Eur Heart J. 1998;19(suppl F):F72-F80. PubMed Show Abstract
39. Pasic J, Levy WC, Sullivan MD. Cytokines in depression and heart failure. Psychosom Med. 2003;65(2):181-193. PubMed doi:10.1097/01.PSY.0000058372.50240.38 Show Abstract
40. Kop WJ, Gottdiener JS. The role of immune system parameters in the relationship between depression and coronary artery disease. Psychosom Med. 2005;67(suppl 1):S37-S41. PubMed doi:10.1097/01.psy.0000162256.18710.4a Show Abstract
41. Redwine LS, Mills PJ, Hong S, et al. Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in heart failure patients. Psychosom Med. 2007;69(1):23-29. PubMed doi:10.1097/PSY.0b013e31802e2f35 Show Abstract
42. Kessler RC, Berglund P, Demler O, et al; National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105. PubMed doi:10.1001/jama.289.23.3095 Show Abstract
43. Beck AT. Depression Inventory. Philadelphia, PA: Center for Cognitive Therapy; 1978.
44. Zung WWK. A self-rating depression scale. Arch Gen Psychiatry. 1965;12(1):63-70. PubMed doi:10.1001/archpsyc.1965.01720310065008 Show Abstract
45. de Jonge P, van den Brink RHS, Spijkerman TA, et al. Only incident depressive episodes after myocardial infarction are associated with new cardiovascular events. J Am Coll Cardiol. 2006;48(11):2204-2208. PubMed doi:10.1016/j.jacc.2006.06.077 Show Abstract
46. Evangelista LS, Moser DK, Westlake C, et al. Correlates of fatigue in patients with heart failure. Prog Cardiovasc Nurs. 2008;23(1):12-17. PubMed Show Abstract
47. Gottlieb SS, Khatta M, Friedmann E, et al. The influence of age, gender, and race on the prevalence of depression in heart failure patients. J Am Coll Cardiol. 2004;43(9):1542-1549. PubMed doi:10.1016/j.jacc.2003.10.064 Show Abstract
48. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), 1: conceptual framework and item selection. Med Care. 1992;30(6):473-483. PubMed doi:10.1097/00005650-199206000-00002 Show Abstract
49. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993;71(12):1106-1107. PubMed doi:10.1016/0002-9149(93)90582-W Show Abstract
50. Evangelista LS, Ter-Galstanyan A, Moughrabi S, et al. Anxiety and depression in ethnic minorities with chronic heart failure. J Card Fail. 2009;15(7):572-579. PubMed doi:10.1016/j.cardfail.2009.03.005 Show Abstract
51. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. PubMed doi:10.1046/j.1525-1497.2001.016009606.x Show Abstract
52. Williams SA, Kasl SV, Heiat A, et al. Depression and risk of heart failure among the elderly: a prospective community-based study. Psychosom Med. 2002;64(1):6-12. PubMed Show Abstract
53. Abramson J, Berger A, Krumholz HM, et al. Depression and risk of heart failure among older persons with isolated systolic hypertension. Arch Intern Med. 2001;161(14):1725-1730. PubMed doi:10.1001/archinte.161.14.1725 Show Abstract
54. May HT, Horne BD, Carlquist JF, et al. Depression after coronary artery disease is associated with heart failure. J Am Coll Cardiol. 2009;53(16):1440-1447. PubMed doi:10.1016/j.jacc.2009.01.036 Show Abstract
55. van Melle JP, de Jonge P, Ormel J, et al; MIND-IT Investigators. Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT. Eur Heart J. 2005;26(24):2650-2656. PubMed doi:10.1093/eurheartj/ehi480 Show Abstract
56. Beck AT, Steer RA. Beck's Depression Inventory Manual. San Antonio, TX: Harcourt Bruce Jovanovich; 1987.
57. de Denus S, Spinler SA, Jessup M, et al. History of depression as a predictor of adverse outcomes in patients hospitalized for decompensated heart failure. Pharmacotherapy. 2004;24(10):1306-1310. PubMed doi:10.1592/phco.24.14.1306.43146 Show Abstract
58. Faris R, Purcell H, Henein MY, et al. Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. Eur J Heart Fail. 2002;4(4):541-551. PubMed doi:10.1016/S1388-9842(02)00101-0 Show Abstract
59. Jünger J, Schellberg D, Müller-Tasch T, et al. Depression increasingly predicts mortality in the course of congestive heart failure. Eur J Heart Fail. 2005;7(2):261-267. PubMed doi:10.1016/j.ejheart.2004.05.011 Show Abstract
60. Murberg TA, Bru E, Aarsland T, et al. Functional status and depression among men and women with congestive heart failure. Int J Psychiatry Med. 1998;28(3):273-291. PubMed doi:10.2190/8TRC-PX8R-N498-7BTP Show Abstract
61. Sullivan MD, Levy WC, Crane BA, et al. Usefulness of depression to predict time to combined end point of transplant or death for outpatients with advanced heart failure. Am J Cardiol. 2004;94(12):1577-1580. PubMed doi:10.1016/j.amjcard.2004.08.046 Show Abstract
62. Vaccarino V, Kasl SV, Abramson J, et al. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol. 2001;38(1):199-205. PubMed doi:10.1016/S0735-1097(01)01334-1 Show Abstract
63. Adams J, Kuchibhatla M, Christopher EJ, et al. Association of depression and survival in patients with chronic heart failure over 12 years. Psychosomatics. 2012;53(4):339-346. PubMed doi:10.1016/j.psym.2011.12.002 Show Abstract
64. Testa G, Cacciatore F, Galizia G, et al. Depressive symptoms predict mortality in elderly subjects with chronic heart failure. Eur J Clin Invest. 2011;41(12):1310-1317. PubMed doi:10.1111/j.1365-2362.2011.02544.x Show Abstract
65. Frasure-Smith N, Lespérance F, Habra M, et al; Atrial Fibrillation and Congestive Heart Failure Investigators. Elevated depression symptoms predict long-term cardiovascular mortality in patients with atrial fibrillation and heart failure. Circulation. 2009;120(2):134-140, 3p, 140. PubMed doi:10.1161/CIRCULATIONAHA.109.851675 Show Abstract
66. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
67. The AF-CHF Trial Investigators. Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J. 2002;144(4):597-607. PubMed Show Abstract
68. Cully JA, Jimenez DE, Ledoux TA, et al. Recognition and treatment of depression and anxiety symptoms in heart failure. Prim Care Companion J Clin Psychiatry. 2009;11(3):103-109. PubMed doi:10.4088/PCC.08m00700 Show Abstract
69. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003;54(3):227-240. PubMed doi:10.1016/S0006-3223(03)00587-0 Show Abstract
70. Thombs BD, de Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA. 2008;300(18):2161-2171. PubMed doi:10.1001/jama.2008.667 Show Abstract
71. Koenig HG, George LK, Peterson BL, et al. Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes. Am J Psychiatry. 1997;154(10):1376-1383. PubMed Show Abstract
72. Bush DE, Ziegelstein RC, Tayback M, et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol. 2001;88(4):337-341. PubMed doi:10.1016/S0002-9149(01)01675-7 Show Abstract
73. Lespérance F, Frasure-Smith N, Talajic M, et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105(9):1049-1053. PubMed doi:10.1161/hc0902.104707 Show Abstract
74. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al; American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008;118(17):1768-1775. PubMed doi:10.1161/CIRCULATIONAHA.108.190769 Show Abstract
75. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284-1292. PubMed doi:10.1097/01.MLR.0000093487.78664.3C Show Abstract
76. Sowden G, Mastromauro CA, Januzzi JL, et al. Detection of depression in cardiac inpatients: feasibility and results of systematic screening. Am Heart J. 2010;159(5):780-787. PubMed doi:10.1016/j.ahj.2010.02.029 Show Abstract
77. McManus D, Pipkin SS, Whooley MA. Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol. 2005;96(8):1076-1081. PubMed doi:10.1016/j.amjcard.2005.06.037 Show Abstract
78. Stafford L, Berk M, Jackson HJ. Validity of the Hospital Anxiety and Depression Scale and Patient Health Questionnaire-9 to screen for depression in patients with coronary artery disease. Gen Hosp Psychiatry. 2007;29(5):417-424. PubMed doi:10.1016/j.genhosppsych.2007.06.005 Show Abstract
79. Hayes D Jr, Anstead MI, Ho J, et al. Insomnia and chronic heart failure. Heart Fail Rev. 2009;14(3):171-182. PubMed doi:10.1007/s10741-008-9102-1 Show Abstract
80. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 3rd ed. Washington, DC: American Psychiatric Association; 2010.
81. Ziffra MS, Gilmer WS. STAR*D: lessons learned for primary care. Prim Psychiatry. 2007;14:51-58.
82. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter violence. Clin Gerontol. 1986;5(1-2):165-173. doi:10.1300/J018v05n01_09
83. Guck TP, Elsasser GN, Kavan MG, et al. Depression and congestive heart failure. Congest Heart Fail. 2003;9(3):163-169. PubMed doi:10.1111/j.1527-5299.2003.01356.x Show Abstract
84. Gary RA, Dunbar SB, Higgins MK, et al. Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure. J Psychosom Res. 2010;69(2):119-131. PubMed doi:10.1016/j.jpsychores.2010.01.013 Show Abstract
85. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. PubMed doi:10.1136/jnnp.23.1.56 Show Abstract
86. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296. PubMed doi:10.1111/j.2044-8260.1967.tb00530.x Show Abstract
87. Blumenthal JA, Babyak MA, O'Connor C, et al. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA. 2012;308(5):465-474. PubMed doi:10.1001/jama.2012.8720 Show Abstract
88. Huffman JC, Mastromauro CA, Boehm JK, et al. Development of a positive psychology intervention for patients with acute cardiovascular disease. Heart Int. 2011;6:47-54.
89. Sin NL, Lyubomirsky S. Enhancing well-being and alleviating depressive symptoms with positive psychology interventions: a practice-friendly meta-analysis. J Clin Psychol. 2009;65(5):467-487. PubMed doi:10.1002/jclp.20593 Show Abstract
90. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1(3):385-401. doi:10.1177/014662167700100306
91. Stahl SM. Essential Psychopharmacology: The Prescriber's Guide (Antidepressants). 3rd ed. New York, NY: Cambridge University Press; 2009.
92. Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT. 2001;17(4):244-253. PubMed doi:10.1097/00124509-200112000-00003 Show Abstract
93. Pagnin D, de Queiroz V, Pini S, et al. Efficacy of ECT in depression: a meta-analytic review. J ECT. 2004;20(1):13-20. PubMed doi:10.1097/00124509-200403000-00004 Show Abstract
94. Figiel GS, McDonald L, LaPlante R. Cardiovascular complications of ECT [letter]. Am J Psychiatry. 1994;151(5):790-791. PubMed
95. Rivera FA, Lapid MI, Sampson S, et al. Safety of electroconvulsive therapy in patients with a history of heart failure and decreased left ventricular systolic heart function. J ECT. 2011;27(3):207-213. PubMed doi:10.1097/YCT.0b013e318223beed Show Abstract
96. Roose SP, Miyazaki M. Pharmacologic treatment of depression in patients with heart disease. Psychosom Med. 2005;67(suppl 1):S54-S57. PubMed doi:10.1097/01.psy.0000163455.43226.bf Show Abstract
97. Nelson JC. Tricyclic and tetracyclic drugs. In: Schatzberg AF, Nemeroff CB, eds. Textbook of Psychopharmacology. 4th ed. Washington, DC: American Psychiatric Publishing; 2009:263-287.
98. Jarvik LF, Read SL, Mintz J, et al. Pretreatment orthostatic hypotension in geriatric depression: predictor of response to imipramine and doxepin. J Clin Psychopharmacol. 1983;3(6):368-372. PubMed doi:10.1097/00004714-198312000-00009 Show Abstract
99. Roose SP, Dalack GW. Treating the depressed patient with cardiovascular problems. J Clin Psychiatry. 1992;53(suppl):25-31. PubMed Show Abstract
100. Shapiro PA. Treatment of depression in patients with congestive heart failure. Heart Fail Rev. 2009;14(1):7-12. PubMed doi:10.1007/s10741-007-9058-6 Show Abstract
101. Amsterdam JD. A double-blind, placebo-controlled trial of the safety and efficacy of selegiline transdermal system without dietary restrictions in patients with major depressive disorder. J Clin Psychiatry. 2003;64(2):208-214. PubMed doi:10.4088/JCP.v64n0216 Show Abstract
102. Amsterdam JD, Bodkin JA. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial. J Clin Psychopharmacol. 2006;26(6):579-586. PubMed doi:10.1097/01.jcp.0000239794.37073.70 Show Abstract
103. Oslin DW, Ten Have TR, Streim JE, et al. Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents. J Clin Psychiatry. 2003;64(8):875-882. PubMed doi:10.4088/JCP.v64n0804 Show Abstract
104. Drent M, Singh S, Gorgels APM, et al. Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine. Am J Respir Crit Care Med. 2003;167(7):958-961. PubMed doi:10.1164/rccm.200207-739CR Show Abstract
105. Cowles MK, Musselman DL, McDonald WM, et al. Effects of mood and anxiety disorders on the cardiovascular system. In: Fuster V, Walsh RA, Harrington RA, eds. Hurst's The Heart, 13th Edition. New York, NY: McGraw-Hill Professional; 2010; 2128-2145.
106. Davidson J, Watkins L, Owens M, et al. Effects of paroxetine and venlafaxine XR on heart rate variability in depression. J Clin Psychopharmacol. 2005;25(5):480-484. PubMed doi:10.1097/01.jcp.0000177547.28961.03 Show Abstract
107. Cheeta S, Schifano F, Oyefeso A, et al. Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000. Br J Psychiatry. 2004;184(1):41-47. PubMed doi:10.1192/bjp.184.1.41 Show Abstract
108. Andrade C, Sandarsh S, Chethan KB, et al. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry. 2010;71(12):1565-1575. PubMed doi:10.4088/JCP.09r05786blu Show Abstract
109. Roose SP, Glassman AH, Attia E, et al. Cardiovascular effects of fluoxetine in depressed patients with heart disease. Am J Psychiatry. 1998;155(5):660-665. PubMed Show Abstract
110. Roose SP, Laghrissi-Thode F, Kennedy JS, et al. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. JAMA. 1998;279(4):287-291. PubMed doi:10.1001/jama.279.4.287 Show Abstract
111. O'Connor CM, Jiang W, Kuchibhatla M, et al; SADHART-CHF Investigators. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial. J Am Coll Cardiol. 2010;56(9):692-699. PubMed doi:10.1016/j.jacc.2010.03.068 Show Abstract
112. Glassman AH, O'Connor CM, Califf RM, et al; Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288(6):701-709. PubMed doi:10.1001/jama.288.6.701 Show Abstract
113. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education and Welfare publication (ADM) 76-338. Bethesda, MD: National Institute of Mental Health; 1976:76-338.
114. Angermann CE, Gelbrich G, Störk S, et al; MOOD-HF Investigators. Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on Morbidity, Mortality and Mood in Depressed Heart Failure patients (MOOD-HF). Eur J Heart Fail. 2007;9(12):1212-1222. PubMed doi:10.1016/j.ejheart.2007.10.005 Show Abstract
115. Figueroa MS, Peters JI. Congestive heart failure: diagnosis, pathophysiology, therapy, and implications for respiratory care. Respir Care. 2006;51(4):403-412. PubMed Show Abstract
116. Scheen AJ. Cytochrome P450-mediated cardiovascular drug interactions. Expert Opin Drug Metab Toxicol. 2011;7(9):1065-1082. PubMed doi:10.1517/17425255.2011.586337 Show Abstract
117. Flockhart DA. Drug interactions: Cytochrome P450 drug interaction table. Indiana School of Medicine (2007). http://medicine.iupui.edu/clinpharm/ddis/table.aspx. Accessed on May 6, 2012.
118. FDA Drug Safety Communication. Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses. http://www.fda.gov/Drugs/DrugSafety/ucm297391.htm. Accessed on July 19, 2012
119. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382-389. PubMed doi:10.1192/bjp.134.4.382 Show Abstract
120. Davidson J, Turnbull CD, Strickland R, et al. The Montgomery-Asberg Depression Scale: reliability and validity. Acta Psychiatr Scand. 1986;73(5):544-548. PubMed doi:10.1111/j.1600-0447.1986.tb02723.x Show Abstract
121. Lambert MJ, Hatch DR, Kingston MD, et al. Zung, Beck, and Hamilton Rating Scales as measures of treatment outcome: a meta-analytic comparison. J Consult Clin Psychol. 1986;54(1):54-59. PubMed doi:10.1037/0022-006X.54.1.54 Show Abstract
122. Löwe B, Unützer J, Callahan CM, et al. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004;42(12):1194-1201. PubMed doi:10.1097/00005650-200412000-00006 Show Abstract
123. Unützer J, Katon W, Williams JW Jr, et al. Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care. 2001;39(8):785-799. PubMed doi:10.1097/00005650-200108000-00005 Show Abstract
124. Derogatis LR, Lipman RS, Covi L. SCL-90: an outpatient psychiatric rating scale-preliminary report. Psychopharmacol Bull. 1973;9(1):13-28. PubMed Show Abstract
125. Derogatis LR. SCL-90-R. Administration, Scoring, and Procedures Manual. 3rd ed. Minneapolis, MN: National Computer Systems, Inc; 1994.
126. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002;32(9):509-515.
127. Nelson JC. Managing treatment-resistant major depression. J Clin Psychiatry. 2003;64(suppl 1):5-12. PubMed Show Abstract
128. Nemeroff CB. Prevalence and management of treatment-resistant depression. J Clin Psychiatry. 2007;68(suppl 8):17-25. PubMed Show Abstract
129. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, et al. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care. 2004;27(2):596-601. PubMed doi:10.2337/diacare.27.2.596 Show Abstract
130. Wilens TE, Hammerness PG, Biederman J, et al. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2005;66(2):253-259. PubMed doi:10.4088/JCP.v66n0215 Show Abstract
131. García-Lizana F, Muñoz-Mayorga I. Telemedicine for depression: a systematic review. Perspect Psychiatr Care. 2010;46(2):119-126. PubMed doi:10.1111/j.1744-6163.2010.00247.x Show Abstract
132. Sullivan M, Simon G, Spertus J, et al. Depression-related costs in heart failure care. Arch Intern Med. 2002;162(16):1860-1866. PubMed doi:10.1001/archinte.162.16.1860 Show Abstract
133. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q. 1996;74(4):511-544. PubMed doi:10.2307/3350391 Show Abstract
134. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2-4. PubMed Show Abstract
135. Rollman BL, Belnap BH. The Bypassing the Blues trial: collaborative care for post-CABG depression and implications for future research. Cleve Clin J Med. 2011;78(suppl 1):S4-S12. PubMed doi:10.3949/ccjm.78.s1.01 Show Abstract
136. Katon WJ, Lin EHB, Von Korff MV, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611-2620. PubMed doi:10.1056/NEJMoa1003955 Show Abstract
137. Rich MW, Beckham V, Wittenberg C, et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333(18):1190-1195. PubMed doi:10.1056/NEJM199511023331806 Show Abstract
138. Asch SM, Baker DW, Keesey JW, et al. Does the collaborative model improve care for chronic heart failure? Med Care. 2005;43(7):667-675. PubMed doi:10.1097/01.mlr.0000167182.72251.a1 Show Abstract
139. Fisher ES. Building a medical neighborhood for the medical home. N Engl J Med. 2008;359(12):1202-1205. PubMed doi:10.1056/NEJMp0806233 Show Abstract
140. Pomerantz AS, Shiner B, Watts BV, et al. The White River model of colocated collaborative care: a platform for mental and behavioral health care in the medical home. Fam Syst Health. 2010;28(2):114-129. PubMed doi:10.1037/a0020261 Show Abstract
141. Davis M, Brennan JM, Vish N, et al. Lessons learned from study of depression in cardiovascular patients in an acute-care heart and vascular hospital. Proc (Bayl Univ Med Cent). 2013;26(1):6-9. PubMed Show Abstract
142. Solberg LI, Trangle MA, Wineman AP. Follow-up and follow-through of depressed patients in primary care: the critical missing components of quality care. J Am Board Fam Pract. 2005;18(6):520-527. PubMed doi:10.3122/jabfm.18.6.520 Show Abstract
143. Wagner EH, Simon GE. Managing depression in primary care. BMJ. 2001;322(7289):746-747. PubMed doi:10.1136/bmj.322.7289.746 Show Abstract
144. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135(9):825-834. PubMed doi:10.7326/0003-4819-135-9-200111060-00012 Show Abstract